Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 10:11:683-687.
doi: 10.2147/OPTH.S128425. eCollection 2017.

Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss

Yogesh Patodia  1 , Elizabeth Golesic  2 , Alex Mao  2 , Cindy Ml Hutnik  2
Affiliations

Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss

Yogesh Patodia et al. Clin Ophthalmol. .

Abstract

Purpose: The aim of this trial is to study the effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss.

Design: This is a randomized pilot clinical trial.

Participants: Sixteen low-vision glaucoma patients participated in this study.

Methods: Patients with a best-corrected visual acuity between 20/70 and 20/400 in the better eye and a diagnosis of stable primary or secondary open-angle glaucoma were randomized to a low-vision treatment group or a nonintervention control group. A telephone interview was conducted before and after the 4-week testing period to assess functional vision. Patients placed in the treatment group received a low-vision examination and used various currently available low-vision aids. Patients placed in the control group received a low-vision examination only. Changes in patients' reading ability and overall visual ability were chosen as the primary outcomes. Other visual functioning domains (mobility, visual information processing and visual motor skills) were considered as secondary outcomes.

Results: Ten patients in the treatment group showed a significant improvement in reading ability and overall visual ability compared to the control group. The difference in mean score for reading ability was 2.52 logits (2.02; P<0.05) and overall visual ability was 0.78 logits (0.64; P<0.05). However, no significant improvement was noted in the other visual functioning domains involving mobility and visual motor skills.

Conclusion: Currently available low-vision devices primarily enhance central vision with limited benefits to functional activities relying on peripheral vision.

Keywords: activities of daily living; glaucoma; low vision; quality of life.

PubMed Disclaimer

Conflict of interest statement

Disclosure The author report no conflicts of interest in this work.

Comment in

References

    1. US Department of Health and Human Services . Vision research – a national plan: 1999–2003. Bethesda, MD: National Eye Institute; 1998. pp. 117–130. (NIH Publication No 98-4120).
    1. Evans K, Law S, Walt J, Buchholz P, Hansen J. The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration. Clin Ophthalmol. 2009;3:433–445. - PMC - PubMed
    1. Department of Veterans Affairs . Coordinated Services for Blinded Veterans IB 11-59 (revised) P87250. Washington, DC: Department of Veterans Affairs; 1996. Veterans Health Administration, Blind Rehabilitation Service.
    1. Stelmack JA, Tang XC, Reda DJ, et al. The Veterans Affairs Low Vision Intervention Trial (LOVIT): design and methodology. Clin Trials. 2007;4(6):650–660. - PubMed
    1. Stelmack JA, Tang XC, Reda DJ, Rinne S, Mancil RM, Massof RW, LOVIT Study Group Outcomes of the Veteran Affairs Low Vision Intervention Trial (LOVIT) Arch Ophthalmol. 2008;126(5):608–617. - PubMed

LinkOut - more resources